Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new…
Read MoreThe World Health Organization said Tuesday the coronavirus pandemic remains a public health emergency, and…
Read MoreThe World Health Organization said Tuesday the coronavirus pandemic remains a public health emergency, and…
Read MoreThe International Monetary Fund has cut its forecast for U.S. growth for the second time…
Read MoreThe administration of President Joe Biden on Tuesday outlined a strategy to manage the dominant…
Read MoreThe administration of President Joe Biden on Tuesday outlined its strategy to manage the dominant…
Read MoreOil futures fell sharply early Tuesday, with the U.S. benchmark slipping back below $100 a…
Read MoreAll adults would become eligible for a second COVID-19 booster shot under a plan being…
Read More
Are chip stocks set up for a short squeeze, or just more declines? Wall Street doesn’t seem sure
Wall Street believes the party is over for the U.S. chip industry, but what that…
Read More